Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
A very good place to experience a lot and move at a fast pace; however, often frustrating due to lack of focus on main objectives for the company.
Was ist das Beste an Ihrem Vergütungspaket?
It is competitive with industry standards
Was gefällt dir am besten am Führungsteam?
Open minded to alternative approaches and collaborative across functions
Was sind einige der besten Dinge an Ihrem Team?
Very collaborative and talented group
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Coworkers are friendly and talented
Was läuft falsch und wie kann es verbessert werden?
Inconsistent goals and constantly shifting priorities by the day. Management rushes too much to push multiple objectives forward which results in work that often must be repeated or adjusted. More focus is needed to focus on a clear set of objectives.
Other Employee Reviews for Karyopharm Therapeutics
×